Showing results (821-830 of 19,464) with videos related to
Sort By:
Pageof 1,947
Lancet (London, England)|November 27, 2012
A healthy nation: strengthening child health research in the UKNeena Modi, Howard Clark, Ingrid Wolfe, et al.Lancet (London, England)|November 27, 2012
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trialGeorge D Demetri, Peter Reichardt, Yoon-Koo Kang, et al.Lancet (London, England)|October 5, 2013
SarcoidosisDominique Valeyre, Antje Prasse, Hilario Nunes, et al.Lancet (London, England)|October 8, 2013
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trialKevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga-Morskaya, et al.Lancet (London, England)|October 8, 2013
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trialCharles S Fuchs, Jiri Tomasek, Cho Jae Yong, et al.Lancet (London, England)|November 10, 1979
Importance of the neural predilection of Mycobacterium leprae in leprosyG L StonerLancet (London, England)|November 17, 1979
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 liversR Y Calne, K Rolles, D J White, et al.Lancet (London, England)|November 17, 1979
Non-surgical treatment of biliary obstructionJ S Dooley, R Dick, J Olney, et al.Lancet (London, England)|November 17, 1979
An erythrocyte membrane-protein anomaly in march haemoglobinuriaJ P Banga, J C Pinder, W B Gratzer, et al.Lancet (London, England)|November 17, 1979
Factor VIII-related antigen (VIII R:AG) in haemophilic patients and in carriersE J Bowie, D N FassPageof 1,947